ArticleTranslational stroke research2023
rs2253820 Variant Controls Blood Pressure Dip After Stroke by Increasing CLOCK-BMAL1 Expression.
Article in Translational stroke research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Research progress on the role and mechanism of circadian clock geneFrontiers in immunology · 2025Review
- Control of circadian rhythm on cortical excitability and synaptic plasticity.Frontiers in neural circuits · 2023Review
- The role of circadian clock in astrocytes: From cellular functions to ischemic stroke therapeutic targets.Frontiers in neuroscience · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circadian rhythm (CR) disturbances are associated with the development of cardiovascular diseases, including stroke. The central clock in the brain, which is maintained by circadian genes, maintains the daily rhythm according to the external environment. Here, we aimed to probe the interaction between the PER1rs2253820 variant and blood pressure dip (BPD) status and mechanisms. We studied spontaneously hypertensive rats (SHR) with transient middle cerebral artery occlusion (SHR-tMCAO). The mutation site of PER1 was identified using bioinformatics analysis, followed by RT-qPCR and western blot validation. SHR-tMCAO showed increased brain infarct volume associated with CR. CK1, BMAL1, and CLOCK proteins oscillated synchronously in SHR-tMCAO, whereas PER1 showed rhythm disturbances. CK1, CLOCK, and BMAL1 levels first elevated and then slowly decreased after ischemia, whereas PER1 level continued to decrease. CLOCK and PER1 are co-localized in the suprachiasmatic nucleus of the hypothalamus. rs2253820 accelerates PER1 phosphorylation via CK1. The rs2253820 knockdown attenuated CR disturbances, reduced PER1 phosphorylation in SHR and inhibited the transcription of BMAL1 and CLOCK. CK1 suppression attenuated the degradation of PER1 phosphorylation and reduced neuronal damage. Overall, rs2253820 accelerated PER1v phosphorylation via CK1, leading to PER1 degradation, BMAL1 and CLOCK1 transcription, and BPD exacerbation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.